| Immunomodulatory effects of sorafenib on peripheral immune effector cells in ... - UroToday |
|
|
UroToday Tyrosine kinase inhibitors (TKI) such as sorafenib have substantially improved the prognosis of metastatic renal cell carcinoma (mRCC) patients, |